Listenly

What was the cost reduction for genome sequencing between previous pharma standards and 2023?

Answered at 5:00 in Transforming Patient Care Through AI and Wearables with Colby Ford of Tuple · Leaders of B2B Podcast - Interviews on Business Leadership, B2B Sales, B2B Marketing and Revenue Growth

— questions searchable right now

What was the cost reduction for genome sequencing between previous pharma standards and 2023?

Previously, pharma companies running clinical trials through sequencing at a CLIA or clinical-grade perspective faced costs over $1,000 per patient just for basic sequencing. In 2023, companies began promising $100 genome sequencing, representing a dramatic cost reduction that makes large-scale genomic analysis feasible.

Colby Ford on Leaders of B2B Podcast - Interviews on Business Leadership, B2B Sales, B2B Marketing and Revenue GrowthAll answers from this podcast →
Full answer and detailsRead the whole answer, key facts and every other question from this episode

In short

Previously, pharma companies running clinical trials through sequencing at a CLIA or clinical-grade perspective faced costs over $1,000 per patient just for basic sequencing.

Colby Ford, Founder and Consulting Partner at Tupul · Transforming Patient Care Through AI and Wearables with Colby Ford of Tuple · Leaders of B2B Podcast - Interviews on Business Leadership, B2B Sales, B2B Marketing and Revenue Growth · answer at 5:00

Key takeaways

  • Previously, pharma companies running clinical trials through sequencing at a CLIA or clinical-grade perspective faced costs over $1,000 per patient just for basic sequencing.

Quote to remember

“If you enter into a partnership, that it is a partnership and it's symbiotic and both parties are getting something out of it.”

— Colby Ford

The full answer · about 1 min

Previously, pharma companies running clinical trials through sequencing at a CLIA or clinical-grade perspective faced costs over $1,000 per patient just for basic sequencing. In 2023, companies began promising $100 genome sequencing, representing a dramatic cost reduction that makes large-scale genomic analysis feasible.

Key facts

  • Genome sequencing cost in pharma clinical trials: over $1,000 per patient (before 2023)
  • Genome sequencing cost promised in 2023: $100 per genome
  • Data size per genome: approximately 100 gigabytes for base information
  • Vendor onboarding timeline for healthcare institutions: up to 6 months in some cases
  • Colby Ford's consulting experience: 20+ years

People, companies and topics mentioned

TupulAmisaMicrosoftDatabricksApple WatchSamsung Galaxy WatchUniversity of North Carolina at CharlotteCyber Center for Infectious Diseases and Pandemic Preparedness

More answers from this episode

 ·  All answers from Leaders of B2B Podcast - Interviews on Business Leadership, B2B Sales, B2B Marketing and Revenue Growth →
—
—
0:00
0:00